Clinical Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia

NCT02575235 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Sarcopenia

Interventions

DRUG: Cetylpyridinium Chloride (CPC)
DRUG: placebo

Sponsor

Seoul National University Hospital